Developer docs
API playgroundTry for free, no card

Search company profiles

Aevice Health

Full company profile

uuid0000tdr

Namestring
Aevice Health
Legal namestring
Aevice Health Pte Ltd
Company typeenum
Private
Founded yearint
2016
Descriptiontext

Aevice Health provides non-invasive wearable technology that enables real-time monitoring of respiratory health. The devices facilitate early detection of cardiopulmonary issues and allow clinicians to track patient responses to treatment effectively. This approach enhances patient care by delivering critical insights directly from home.

Short descriptiontext

Aevice Health offers wearable devices for remote monitoring of respiratory conditions.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSingapore, Singapore
HQ citystring
Singapore
HQ countrystring
Singapore
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
remote patient monitoring, wearable medical devices, respiratory health monitoring, digital auscultation, chronic disease management
Industry4 codes
1Respiratory Monitoring & Oximetry (Capnography, Pulse Oximeters, Respiratory Rate)
CodeHLAHAGAIPrimaryYes
2Chronic Disease Management IoT (Diabetes, CHF, COPD, Hypertension)
CodeHLACAPADPrimaryNo
3Medical-Grade Device Connectivity & Device Management (MDM)
CodeHLACAFAGPrimaryNo
4Pulmonology & Sleep Medicine Telemedicine Platforms
CodeHLALAGAFPrimaryNo
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing3345
SIC code2 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Surgical & Medical Instruments & Apparatus3841
Product category
Remote Patient Monitoring Medical Devices
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Hardware Sales (AeviceMD Device)
TypeHardware Sales
Description

Sale of the AeviceMD wearable stethoscope device to healthcare providers, hospitals, and clinics. The device is provided to patients through healthcare provider programs, not sold directly to patients.

aevice.com
2Remote Patient Monitoring Services
TypeSubscription Recurring
Description

Subscription-based remote patient monitoring platform enabling continuous respiratory monitoring, data analytics, and clinician dashboard access for chronic respiratory disease management.

aevice.com
3Healthcare Provider Partnerships
TypeManaged Services
Description

Partnerships with healthcare providers like Parkway MediCentre for pediatric asthma monitoring programs. Device made available to eligible patients through pediatrician supervision.

aevice.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales
Pricing details1 tier
1Healthcare Provider Program
ModelSubscriptionBilling cadenceMulti-year contract
Notes

AeviceMD is provided to patients through healthcare provider programs under pediatrician supervision. Pricing negotiated through institutional partnerships.

aevice.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1AeviceMD
Description

Flagship smart wearable stethoscope and remote patient monitoring platform for chronic respiratory disease management, featuring wheeze detection, heart rate monitoring, respiratory rate measurement, and digital auscultation.

aevice.com
Core offering1 text field

Aevice Health develops and sells the AeviceMD Monitoring System, a Class II medical device comprising a small wearable smart stethoscope sensor, a patient mobile app, and a healthcare provider web portal. The system continuously monitors lung sounds, detects wheezing, tracks heart rate and respiratory rate, and enables digital auscultation for telehealth consultations, supporting chronic respiratory disease management for patients aged 3 and above.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 47% decrease in likelihood of asthma attacks in patients with good management of their condition
+3 more records
Product overview1 text field

Aevice Health offers the AeviceMD Monitoring System, a unified remote respiratory care platform combining a wearable smart stethoscope sensor with patient mobile app and healthcare provider web portal modules. The flagship AeviceMD wearable sensor serves as the core data collection device, capturing continuous lung sounds, wheeze detection, heart rate, and respiratory rate. The patient mobile app enables medication tracking, real-time monitoring, and remote auscultation sharing. The provider web portal delivers patient management with risk-scored profiles, vital signs dashboards, and telehealth facilitation capabilities. Whitepapers on Virtual Asthma Care and Digital Auscultation support implementation and clinical adoption.

Product and service2 records
1AeviceMD Monitoring System
CategoryRemote Patient Monitoring Platform
Description

Comprehensive remote patient monitoring platform for chronic respiratory disease management, combining a wearable smart stethoscope sensor, patient mobile app, and healthcare provider web portal. Continuously monitors lung sounds, detects wheeze, tracks heart rate and respiratory rate, and enables digital auscultation for telehealth consultations for patients aged 3 and above.

2AeviceMD Wearable Sensor
CategoryWearable Medical Device
Description

The world's smallest wearable smart stethoscope (9 grams, 1.2 inches diameter) that attaches to the chest via silicone patch for non-invasive continuous monitoring of cardiopulmonary sounds during sleep and daily activities. FDA 510(k) cleared, HSA approved in Singapore, and TGA certified in Australia.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
1Parkway MediCentre
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-06-08
Description

Home-based paediatric asthma monitoring programme partnership. AeviceMD integrated into paediatric care pathways. Available at Parkway MediCentre @ The Woodleigh Mall. Part of IHH Healthcare Singapore's ambulatory care network.

aevice.com
2Jiva.ai
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2024-02-02
Description

Co-innovation programme funded by Innovate UK and Enterprise Singapore to develop AI-powered asthma exacerbation prediction. Combined AeviceMD with Jiva.ai's model-fusion AI platform. Achieved over 60% prediction accuracy across 24, 48, and 72-hour windows using data from 185 patients.

aevice.com
3Cedars-Sinai
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2023-07-20
Description

Clinical collaboration through Cedars-Sinai Accelerator Class 8 program. Mentorship from clinical key opinion leaders, executive management, operations members. Pilot program with Cedars-Sinai Medical Center.

aevice.com
4National University Health System (NUHS)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-10-27
Description

Clinical study at National University Hospital (NUH) to validate AeviceMD in detecting lung sound abnormalities in paediatric patients. Coordinated through NUHS Centre for Innovation in Healthcare (CIH).

aevice.com
5Toho Holdings
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2021-06-15
Description

Strategic collaboration to expand into Japan market. Toho Holdings operates over 700 pharmacies across Japan. Joint development and commercialization of AeviceMD for Japanese patients with chronic respiratory diseases.

aevice.com
6THB Global
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2021-06-15
Description

Partnership to advance remote monitoring of chronic respiratory diseases in MENASA region (Middle East, North Africa, and South Asia). THB Global has offices in Singapore, Dubai, and Karachi.

aevice.com
7A*STAR Singapore
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2020-01-14
Description

Research collaboration to develop predictive model for asthma attack among children using continuous measures from wearable device. Supported by HealthTEC Singapore seed grant.

aevice.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1ResMed
TypeBroad incumbent
Description

Global leader in sleep and respiratory care devices, with a growing connected health portfolio including Propeller Health for respiratory RPM. Comparable as a respiratory-focused medtech with continuous-monitoring hardware, software platform, and recurring revenue model; substantially larger and more established than Aevice.

2Propeller Health (ResMed)
TypeDirect peer
Description

Digital respiratory health platform (acquired by ResMed) offering connected inhalers and RPM software for asthma and COPD. Directly comparable as an asthma/COPD remote monitoring solution targeting the same patient populations and healthcare provider buyers that Aevice serves.

3Philips (Connected Care / RPM)
TypeBroad incumbent
Description

Diversified medtech incumbent with a broad RPM and hospital monitoring portfolio (including biosensor-based RPM via its acquisition of BioTelemetry). Comparable as a large-scale provider of respiratory and chronic disease RPM solutions to hospitals and health systems.

4Eko Health
TypeDirect peer
Description

Developer of AI-powered digital stethoscopes and cardiopulmonary auscultation software for clinicians. Directly comparable as an AI-augmented smart stethoscope company with FDA-cleared devices, AI-driven lung/heart sound analysis, and telehealth integration - a parallel product category to AeviceMD.

5StethoMe
TypeDirect peer
Description

Poland-based digital health company offering an AI-powered electronic stethoscope for remote respiratory monitoring, with CE-marked pediatric and adult solutions. Closely comparable to Aevice as a smart stethoscope with wheeze/asthma detection targeting home monitoring and pediatric care.

6Sonavi Labs
TypeEmerging player
Description

Developer of an AI-powered digital stethoscope (Feelix) for respiratory disease detection and remote monitoring. Comparable as an emerging smart-stethoscope player focused on automated lung sound analysis and telehealth enablement, with similar early-stage scale to Aevice.

7Tytocare
TypeDirect peer
Description

Provider of a remote medical examination device that captures heart and lung sounds for teleconsultation. Comparable as a remote auscultation and virtual care platform enabling clinicians to assess patients at home, overlapping with Aevice's teleconsultation use cases.

8Current Health (Best Buy Health)
TypeDirect peer
Description

Acquired by Best Buy Health, Current Health provides a wearable RPM platform for continuous vital sign monitoring at home, including respiratory rate. Comparable as a wearable-based RPM solution for chronic disease management targeting hospital and health system customers.

9Biofourmis
TypeDirect peer
Description

AI-driven RPM platform combining wearable biosensors with predictive analytics for chronic and acute condition management, with respiratory applications. Comparable as a device-plus-AI RPM platform sold to health systems and providers, with a subscription/enterprise model similar to Aevice's.

10VitalConnect
TypeEmerging player
Description

Provider of wearable biosensor patches (VitalPatch) for continuous cardiac and respiratory monitoring in hospital and home settings. Comparable as a wearable, FDA-cleared continuous-monitoring patch company with a hospital-focused GTM motion.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds10 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors14 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Aevice Health

Remote Patient Monitoring Medical Devicesaevice.com

Aevice Health offers wearable devices for remote monitoring of respiratory conditions.

What Aevice Health does

Aevice Health provides non-invasive wearable technology that enables real-time monitoring of respiratory health. The devices facilitate early detection of cardiopulmonary issues and allow clinicians to track patient responses to treatment effectively. This approach enhances patient care by delivering critical insights directly from home.

Aevice Health firmographics

Firmographics
Name
Aevice Health
Legal name
Aevice Health Pte Ltd
Website
https://www.aevice.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
11–50 employees
Short description
Aevice Health offers wearable devices for remote monitoring of respiratory conditions.
Ownership category
akta.pro rank

Aevice Health industry classification

Industry
Product category
Remote Patient Monitoring Medical Devices
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
akta.pro primary industry
Respiratory Monitoring & Oximetry (Capnography, Pulse Oximeters, Respiratory Rate) (HLAHAGAI)
akta.pro secondary industries
Chronic Disease Management IoT (Diabetes, CHF, COPD, Hypertension) (HLACAPAD), Medical-Grade Device Connectivity & Device Management (MDM) (HLACAFAG), Pulmonology & Sleep Medicine Telemedicine Platforms (HLALAGAF)

Keywords

  • Remote patient monitoring
  • Wearable medical devices
  • Respiratory health monitoring
  • Digital auscultation
  • Chronic disease management

Where Aevice Health is headquartered

Location

Headquarters

HQ city
Singapore
HQ country
Singapore
HQ region
Asia

Offices1 record

Markets served

Aevice Health business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales

Revenue model

  1. Hardware Sales (AeviceMD Device): Sale of the AeviceMD wearable stethoscope device to healthcare providers, hospitals, and clinics. The device is provided to patients through healthcare provider programs, not sold directly to patients.
  2. Remote Patient Monitoring Services: Subscription-based remote patient monitoring platform enabling continuous respiratory monitoring, data analytics, and clinician dashboard access for chronic respiratory disease management.
  3. Healthcare Provider Partnerships: Partnerships with healthcare providers like Parkway MediCentre for pediatric asthma monitoring programs. Device made available to eligible patients through pediatrician supervision.

Pricing tiers

ModelBillingPrice
SubscriptionMulti-year contractHealthcare Provider Program

Go-to-market motion3 records

Distribution channels3 records

Marketing channels5 records

Aevice Health product offering

Product offering

Core offering

Aevice Health develops and sells the AeviceMD Monitoring System, a Class II medical device comprising a small wearable smart stethoscope sensor, a patient mobile app, and a healthcare provider web portal. The system continuously monitors lung sounds, detects wheezing, tracks heart rate and respiratory rate, and enables digital auscultation for telehealth consultations, supporting chronic respiratory disease management for patients aged 3 and above.

Product overview

Aevice Health offers the AeviceMD Monitoring System, a unified remote respiratory care platform combining a wearable smart stethoscope sensor with patient mobile app and healthcare provider web portal modules. The flagship AeviceMD wearable sensor serves as the core data collection device, capturing continuous lung sounds, wheeze detection, heart rate, and respiratory rate. The patient mobile app enables medication tracking, real-time monitoring, and remote auscultation sharing. The provider web portal delivers patient management with risk-scored profiles, vital signs dashboards, and telehealth facilitation capabilities. Whitepapers on Virtual Asthma Care and Digital Auscultation support implementation and clinical adoption.

Differentiator

Problem solved

Functional benefit

Brands

  • AeviceMD: Flagship smart wearable stethoscope and remote patient monitoring platform for chronic respiratory disease management, featuring wheeze detection, heart rate monitoring, respiratory rate measurement, and digital auscultation.

Products and services

  • AeviceMD Monitoring System Comprehensive remote patient monitoring platform for chronic respiratory disease management, combining a wearable smart stethoscope sensor, patient mobile app, and healthcare provider web portal. Continuously monitors lung sounds, detects wheeze, tracks heart rate and respiratory rate, and enables digital auscultation for telehealth consultations for patients aged 3 and above.
  • AeviceMD Wearable Sensor The world's smallest wearable smart stethoscope (9 grams, 1.2 inches diameter) that attaches to the chest via silicone patch for non-invasive continuous monitoring of cardiopulmonary sounds during sleep and daily activities. FDA 510(k) cleared, HSA approved in Singapore, and TGA certified in Australia.

Quantifiable outcome

  • 47% decrease in likelihood of asthma attacks in patients with good management of their condition
  • +3 more outcomes

Companies that use Aevice Health

Customer profile

Named customers4 records

Segments3 records

Ideal customer profiles1 record

Aevice Health technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature6 records

Aevice Health partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered core, flagship and minor.

  • Parkway MediCentrecoreChannel Partner/ Reseller/ Distributor · 8 June 2026Home-based paediatric asthma monitoring programme partnership. AeviceMD integrated into paediatric care pathways. Available at Parkway MediCentre @ The Woodleigh Mall. Part of IHH Healthcare Singapore's ambulatory care network.
  • Jiva.aicoreTechnology or Integration · 2 February 2024Co-innovation programme funded by Innovate UK and Enterprise Singapore to develop AI-powered asthma exacerbation prediction. Combined AeviceMD with Jiva.ai's model-fusion AI platform. Achieved over 60% prediction accuracy across 24, 48, and 72-hour windows using data from 185 patients.
  • Cedars-SinaiflagshipStrategic or Co-development Partner · 20 July 2023Clinical collaboration through Cedars-Sinai Accelerator Class 8 program. Mentorship from clinical key opinion leaders, executive management, operations members. Pilot program with Cedars-Sinai Medical Center.
  • National University Health System (NUHS)coreStrategic or Co-development Partner · 27 October 2021Clinical study at National University Hospital (NUH) to validate AeviceMD in detecting lung sound abnormalities in paediatric patients. Coordinated through NUHS Centre for Innovation in Healthcare (CIH).
  • Toho HoldingscoreChannel Partner/ Reseller/ Distributor · 15 June 2021Strategic collaboration to expand into Japan market. Toho Holdings operates over 700 pharmacies across Japan. Joint development and commercialization of AeviceMD for Japanese patients with chronic respiratory diseases.
  • THB GlobalminorStrategic or Co-development Partner · 15 June 2021Partnership to advance remote monitoring of chronic respiratory diseases in MENASA region (Middle East, North Africa, and South Asia). THB Global has offices in Singapore, Dubai, and Karachi.
  • A*STAR SingaporecoreStrategic or Co-development Partner · 14 January 2020Research collaboration to develop predictive model for asthma attack among children using continuous measures from wearable device. Supported by HealthTEC Singapore seed grant.

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

Aevice Health competitors and assessment

Company assessment

Broad incumbents

  • ResMed: Global leader in sleep and respiratory care devices, with a growing connected health portfolio including Propeller Health for respiratory RPM. Comparable as a respiratory-focused medtech with continuous-monitoring hardware, software platform, and recurring revenue model; substantially larger and more established than Aevice.
  • Philips (Connected Care / RPM): Diversified medtech incumbent with a broad RPM and hospital monitoring portfolio (including biosensor-based RPM via its acquisition of BioTelemetry). Comparable as a large-scale provider of respiratory and chronic disease RPM solutions to hospitals and health systems.

Direct peers

  • Propeller Health (ResMed): Digital respiratory health platform (acquired by ResMed) offering connected inhalers and RPM software for asthma and COPD. Directly comparable as an asthma/COPD remote monitoring solution targeting the same patient populations and healthcare provider buyers that Aevice serves.
  • Eko Health: Developer of AI-powered digital stethoscopes and cardiopulmonary auscultation software for clinicians. Directly comparable as an AI-augmented smart stethoscope company with FDA-cleared devices, AI-driven lung/heart sound analysis, and telehealth integration - a parallel product category to AeviceMD.
  • StethoMe: Poland-based digital health company offering an AI-powered electronic stethoscope for remote respiratory monitoring, with CE-marked pediatric and adult solutions. Closely comparable to Aevice as a smart stethoscope with wheeze/asthma detection targeting home monitoring and pediatric care.
  • Tytocare: Provider of a remote medical examination device that captures heart and lung sounds for teleconsultation. Comparable as a remote auscultation and virtual care platform enabling clinicians to assess patients at home, overlapping with Aevice's teleconsultation use cases.
  • Current Health (Best Buy Health): Acquired by Best Buy Health, Current Health provides a wearable RPM platform for continuous vital sign monitoring at home, including respiratory rate. Comparable as a wearable-based RPM solution for chronic disease management targeting hospital and health system customers.
  • Biofourmis: AI-driven RPM platform combining wearable biosensors with predictive analytics for chronic and acute condition management, with respiratory applications. Comparable as a device-plus-AI RPM platform sold to health systems and providers, with a subscription/enterprise model similar to Aevice's.

Emerging players

  • Sonavi Labs: Developer of an AI-powered digital stethoscope (Feelix) for respiratory disease detection and remote monitoring. Comparable as an emerging smart-stethoscope player focused on automated lung sound analysis and telehealth enablement, with similar early-stage scale to Aevice.
  • VitalConnect: Provider of wearable biosensor patches (VitalPatch) for continuous cardiac and respiratory monitoring in hospital and home settings. Comparable as a wearable, FDA-cleared continuous-monitoring patch company with a hospital-focused GTM motion.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

Aevice Health social profiles

Digital presence

Aevice Health compliance and trust

Trust signal

Compliance5 records

Aevice Health financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Aevice Health leadership team

Management profile

Number of profiles

Profiles5 records

Aevice Health funding detail

Funding detail

Funding overview

Funding rounds10 records

Investors14 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Aevice Health M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Aevice Health

What does Aevice Health do?

Aevice Health develops and sells the AeviceMD Monitoring System, a Class II medical device comprising a small wearable smart stethoscope sensor, a patient mobile app, and a healthcare provider web portal. The system continuously monitors lung sounds, detects wheezing, tracks heart rate and respiratory rate, and enables digital auscultation for telehealth consultations, supporting chronic respiratory disease management for patients aged 3 and above.

Is Aevice Health a public or private company?

Aevice Health is a private company. It is classified as venture growth investor backed and is currently operating.

When was Aevice Health founded?

Aevice Health was founded in 2016. It employs 11 to 50 people.

Where is Aevice Health based?

Aevice Health is headquartered in Singapore, Singapore, in the Asia region.

How does Aevice Health make money?

Three revenue lines are on record. Hardware Sales (AeviceMD Device) is the primary driver. The others are remote Patient Monitoring Services and healthcare Provider Partnerships.

Who are Aevice Health's main competitors?

Broad incumbents on record are ResMed and Philips (Connected Care / RPM). Direct peers are Propeller Health (ResMed), Eko Health, StethoMe, Tytocare, Current Health (Best Buy Health) and Biofourmis. Emerging players are Sonavi Labs and VitalConnect.

Does Aevice Health have an API?

No public API is recorded for Aevice Health.

What industry is Aevice Health in?

Aevice Health's product category is Remote Patient Monitoring Medical Devices. Its primary akta.pro industry code is HLAHAGAI, Respiratory Monitoring & Oximetry (Capnography, Pulse Oximeters, Respiratory Rate), with a secondary code of HLACAPAD, Chronic Disease Management IoT (Diabetes, CHF, COPD, Hypertension). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
IntelligenthealthCollaboration harnesses AI to predict asthma exacerbations on wearable patient monitors – Intelligent Health.techJiva.ai and Aevice Health completed a three-year UK-Singapore innovation programme funded by Innovate UK and Enterprise Singapore, successfully developing AI-powered technology that predicts asthma exacerbations with over 60% accuracy. The collaboration combined AeviceMD, an FDA-cleared wearable stethoscope, with Jiva.ai's model-fusion AI platform, analyzing anonymized data from 185 patients across multiple clinical sites to enable predictions within 24, 48, and 72-hour windows. The two companies are now exploring the next phase of clinical validation and regulatory development to advance the technology toward commercial deployment, addressing a condition that affects over 545 million people worldwide.The Business Times‘10% is nothing’: Singapore firms with US dealings soldier on, scale up despite Trump tariffsSingapore companies with US operations are continuing to expand and invest in the American market despite the 10% baseline tariff imposed by President Trump in April 2025, with over 250 Singaporean firms now operating across more than 45 US states. Companies including snack maker Irvins, digital lock manufacturer Igloo, satellite communications firm Transcelestial, medical technology company Aevice Health, and semiconductor equipment maker AEM are absorbing or passing on tariff costs, citing the US market's scale, talent pool, and growth opportunities as outweighing the financial headwinds. The US was Singapore's fourth largest trade partner in 2025 with S$139.2 billion in total trade, and Singapore exported S$27 billion in non-oil domestic exports to the US last year.Channel NewsAsiaSome Singapore firms eye US expansion despite trade and regulatory challengesAbout 30 Singapore companies are attending the SelectUSA Investment Summit in Maryland this week, marking the country's largest contingent in recent years as they seek to expand into the US market. Singapore-based firms including medtech company Aevice Health and deep-tech firm Transcelestial are actively pursuing US growth despite challenges from tariff uncertainty and regulatory complexity, with Transcelestial already reporting that its US business has surpassed all other markets combined. Enterprise Singapore is supporting these companies through its newly opened overseas office in Austin, Texas, which aims to facilitate partnerships and keep Singapore firms informed of US infrastructure opportunities.openPR.comAn Overview of Segmentation, Market Dynamics, and Competitive Landscape in the Intelligent Asthma Monitoring Devices MarketThe intelligent asthma monitoring devices market is projected to reach $1.52 billion by 2030, growing at a compound annual growth rate of 7.0%, driven by rising demand for digital health tools, connected medical devices, and personalized respiratory care. Key developments include the February 2024 partnership between Singapore's Aevice Health and UK-based Jiva.ai to develop an AI-powered remote monitoring system for asthma patients, and the May 2023 launch of the AsthmaGo app by US-based CMI Health Inc. The market is segmented by product type (wearable devices and smart inhalers), distribution channel (retail and online pharmacies), and end user (hospitals, clinics, and others).Mpo-magTGA Certification Granted to Aevice Health’s Wearable StethoscopeAevice Health's wearable respiratory monitoring solution received TGA approval in Australia, leading to its registration as a Class IIa medical device. This device, the AeviceMD Monitoring System, is the first of its kind in Australia to integrate wheeze detection, heart and respiratory rate measurements, and digital auscultation for patients aged 3 and above.Corporate NTUFrom lab to startupNanyang Technological University (NTU) alumni have launched three startups—Aliena, Eureka Robotics, and Aevice Health—leveraging research from their PhD studies to develop advanced technologies in space propulsion, industrial robotics, and healthcare monitoring. These companies have secured significant funding, regulatory approvals, and industry partnerships while maintaining close operational ties with NTU through talent pipelines and facility usage.Life Science Company NewsSingapore-based startup Aevice Health secures additional funding to expand market presenceAevice Health, a Singapore-based medtech startup, secured additional funding from Denka Co., Ltd. and Elev8.vc to accelerate the development and global deployment of respiratory health monitoring solutions.AeviceAevice Health Secures US$7M Seed Plus Round Led By Coronet Ventures to Expand Accessible Respiratory Care GloballyAevice Health has secured a US$7 million Seed Plus funding round led by Coronet Ventures to expand its remote respiratory care solutions globally. The company plans to utilize the investment to advance operations in key markets including the US, Japan, and Singapore, leveraging the networks of participating investors such as East Ventures and A&D Company.DealStreetAsiaSG medtech firm Aevice Health raises $7m in seed extension fundingSingapore-based medtech firm Aevice Health has raised $7 million in seed extension funding. The article includes a photo caption featuring Coronet Ventures CEO Nirdesh Gupta and Aevice Health co-founder and CEO Adrian Ang.SbrSG-based VC firm invests in remote respiratory monitoring healthcare startupSingapore-based healthcare startup Aevice Health has secured undisclosed funding from venture capital firm East Ventures to expand its remote respiratory monitoring solutions. The company plans to utilize the investment to increase access to its AeviceMD Monitoring System for patients suffering from chronic respiratory diseases in Southeast Asia.